Fig 2. The expression pattern of eIF5AHyp in T2D and control pancreatic tissue.
In controls (matched for age, gender and BMI) and T2D pancreas, we evaluated the co-expression of eIF5AHyp with all islet hormones and found no overlap with insulin (A,B), glucagon (C,D), ghrelin (E,F) or somatostatin (G,H).